Prolonged treatment with recombined growth hormone improves bone measures: Study of body composition in 21 deficient adults on treatment;Le traitement prolongé par hormone de croissance recombinante améliore les paramètres osseux: Étude de composition corporelle chez 21 patients adultes déficients substitués

Annales d'Endocrinologie

Volumn 62, Issue 6, 2001, Pages 507-515

  Beckers, V ^a   Milet, J ^a   Legros, J J ^a  

^a Service d'Endocrinologie   (Belgium)

Author keywords

Adult growth hormone deficiency; Bone mineral content; Bone mineral density

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; LEAN BODY WEIGHT; MALE; OSTEOPENIA;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CHILD; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOPHYSECTOMY; HYPOPITUITARISM; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MINERALS; MUSCLE, SKELETAL; RECOMBINANT PROTEINS; TIME FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 0035688710     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency
2. The use of growth hormone in adults: A review of the last 10 years, the present and a perspective for the future
3. Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset deficiency
4. The effect of Growth Hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men
5. The growth hormone deficiency syndrome in adults
6. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers
7. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement
8. Effects of GH on bone at the cellular and subcellular levels
9. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency
10. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
11. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
12. Growth hormone therapy and fracture risk in the growth hormone-deficient adult
13. Growth hormone and bone
14. Evaluation of dual-energy X-ray absorptiometry for body-composition assessment in piglets and term human neonates
15. Long-term change in the bone mineral density of adults with adult-onset growth hormone (GH) deficiency in response to short- or long-term GH replacement therapy
16. Reference values of body composition obtained by dual energy X-ray absorptiometry in preterm and term neonates
17. Bone function, structure and metabolism
18. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Need for additional growth hormone substitution?